🔎 Trials Near Me

Utama › Kanser Paru-paru Bukan Sel Kecil › Tennessee › Memphis

Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Memphis, TN

23 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Memphis (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Mengambil pesertaFasa 3
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi jauh
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04267848

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Mengambil pesertaFasa 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi jauh
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07293247

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Mengambil pesertaFasa 3
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi jauh
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06498635

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Mengambil pesertaFasa 3
  • Baptist Cancer Center, Memphis
  • Baptist Clinical Research Institute, Memphis
  • Baptist Cancer Center, Bartlett · 11 mi jauh
  • dan 3 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07144280

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Mengambil pesertaFasa 2
  • Research Site, Memphis
Umur 18 hingga 95 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05061550

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

Mengambil pesertaFasa 2
  • Baptist Clinical Research Institute, Memphis
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06745882

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Mengambil pesertaFasa 2/3
  • West Cancer Center & Research Institute - East Campus, Germantown · 14 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT04613596

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Mengambil pesertaFasa 2
  • Baptist Clinical Research Institute, Memphis
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT04302025

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Baptist Memorial Hospital-Memphis, Memphis
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Mengambil pesertaFasa 3
  • Research Site, Memphis
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07291037

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Mengambil pesertaFasa 1
  • The West Clinic, PLLC dba West Cancer Center, Germantown · 14 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06764771

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Mengambil pesertaFasa 1/2
  • Baptist Medical Center, Memphis
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jun 2026 · NCT06162221

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Mengambil pesertaFasa 2
  • Baptist Cancer Center, Memphis
Umur 18 hingga 70 · Semua jantina · Dikemas kini 26 Jun 2026 · NCT04614103

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi jauh
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT05642572

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Mengambil pesertaFasa 1/2
  • Baptist Memorial Hospital Baptist Cancer Center, Memphis
Umur 12 ke atas · Semua jantina · Dikemas kini 27 Mei 2026 · NCT03093116

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi jauh
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi jauh
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi jauh
18 Minutes · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2/3
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi jauh
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06616584

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Mengambil pesertaKajian pemerhatian
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital for Women, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southaven · 11 mi jauh
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06418204

GEMINI-NSCLC: NSCLC Biomarker Study

Mengambil pesertaKajian pemerhatian
  • Baptist Cancer Center, Memphis
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Feb 2026 · NCT05236114

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Memphis
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain

Kajian lain di Memphis

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.